CN

Challa Noel Reddy

Active Director Director DIN 11459201
DIN 11459201 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Challa Noel Reddy

Data last updated:

Challa Noel Reddy is a Director at Rhudhra Biotech Private Limited (since 2026) and Designated Partner at Gyann Llp (since 2025).

DIN 11459201
Primary Designation Director
First Appointment 31 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rhudhra Biotech Private Limited U17092TS2026PTC210895
Director07 Feb 20262026Active
Gyann Llp ACT-9015
Designated Partner31 Dec 20252025Inactive For E-Filing

Board colleagues of Challa Noel Reddy

Directorship timeline

Open interactive timeline →
Gyann Llp
Rhudhra Biotech Private Limited
Premium access

Shareholding and investment profile for Challa Noel Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Challa Noel Reddy

Challa Noel Reddy currently holds 2 directorships: Rhudhra Biotech Private Limited (Director, since 07 Feb 2026); Gyann Llp (Designated Partner, since 31 Dec 2025).

Challa Noel Reddy was first appointed on 31 Dec 2025 as Designated Partner at Gyann Llp. The most recent appointment on record is 07 Feb 2026 at Rhudhra Biotech Private Limited.

The current boards of Challa Noel Reddy's companies include Bollapragada Venkata Dharma Satya Sai Pavan Kumar (Rhudhra Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available